Changes of pathogens for community-acquired pneumonia_West China Medical Journal

Authors：

 FAN Hong , SHEN Yongchun , TONG Xiang

Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

FAN Hong, Email: fanhongfan@qq.com

Keywords：

Community-acquired pneumonia; Pathogen; Change

DOI：

10.7507/1002-0179.201710136

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Community-acquired pneumonia (CAP) is still a common disease that seriously affects people’s health. It is of great clinical significance for proper anti-infective therapy to identify the characteristics and changes of the pathogens. Along with the accelerated process of aging population, increased use of immunosuppression agents, and increased morbidity of malignant tumor and underlying diseases, the pathogenic spectrum of patients with CAP varies as well. This article reviews the important pathogenic changes of CAP in recent years.

Citation： FAN Hong, SHEN Yongchun, TONG Xiang. Changes of pathogens for community-acquired pneumonia. West China Medical Journal, 2018, 33(1): 84-87. doi: 10.7507/1002-0179.201710136 Copy

1.	中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南 (2016 年版). 中华结核和呼吸杂志, 2016, 39(4): 253-279.
2.	Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax, 2009, 64(Suppl 3): iii1-iii55.
3.	Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U. S. Adults. N Engl J Med, 2015, 373(5): 415-427.
4.	国家卫生和计划生育委员会统计信息中心. 中国卫生和计划生育统计年鉴. (2014-04-26)［2017-10-20］. http://www.nhfpc.gov. cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.html.
5.	Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet, 2015, 386(9998): 1097-1108.
6.	Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis, 2007, 44(Suppl 2): S27-S72.
7.	Boyles TH, Brink A, Calligaro GL, et al. South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis, 2017, 9(6): 1469-1502.
8.	Miyashita N, Matsushima T, Oka M. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med, 2006, 45(7): 419-428.
9.	Rozenbaum MH, Pechlivanoglou P, van der Werf T, et al. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis, 2013, 32(3): 305-316.
10.	Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia - etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest, 2000, 118(5): 1344-1354.
11.	Liu Y, Chen M, Zhao T, et al. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population. BMC Infect Dis, 2009, 9: 31.
12.	Tao LL, Hu BJ, He LX, et al. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J (Engl), 2012, 125(17): 2967-2972.
13.	李群, 李为民, 高属生, 等. 四川地区社区获得性肺炎的病原学调查. 华西医学, 2008, 23(2): 275-277.
14.	Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med, 2016, 37(6): 819-828.
15.	Marchello C, Dale AP, Thuy NT, et al. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a Meta-analysis. Ann Fam Med, 2016, 14(6): 552-566.
16.	刘又宁, 陈民钧, 赵铁梅, 等. 中国城市成人社区获得性肺炎 665 例病原学多中心调查. 中华结核和呼吸杂志, 2006, 29(1): 3-8.
17.	熊祎虹, 邓锐, 付荣荣, 等. 非典型病原菌致成人社区获得性肺炎患者的临床特点分析. 中华结核和呼吸杂志, 2010, 33(9): 646-650.
18.	Rocha NO, Leite RF, Baldi BG. Update on viral community-acquired pneumonia. Rev Assoc Med Bras, 2013, 59(1): 78-84.
19.	Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax, 2008, 63(1): 42-48.
20.	Charles PG, Whitby M, Fuller AJ, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis, 2008, 46(10): 1513-1521.
21.	Alimi Y, Lim WS, Lansbury L, et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol, 2017, 95: 26-35.
22.	刘雅芬, 陈美芳, 高燕, 等. 北京地区成人社区获得性肺炎病原学分析. 中华医学杂志, 2013, 93(26): 2043-2047.
23.	邓紫薇, 仇成凤, 李茂作, 等. 成人社区获得性肺炎主要病原体分布的 Meta 分析. 中国抗生素杂志, 2016, 41(12): 950-955.
24.	佘丹阳. 我国成人社区获得性肺炎病原学与欧美国家的差异. 中华结核和呼吸杂志, 2015, 38(1): 13-15.
25.	赵爽, 邓旺, 王导新, 等. 老年性社区获得性肺炎病原菌及药敏结果分析. 中华老年多器官疾病杂志, 2015, 14(3): 215-219.
26.	Cillóniz C, Civljak R, Nicolini A, et al. Polymicrobial community-acquired pneumonia: an emerging entity. Respirology, 2016, 21(1): 65-75.
27.	Burk M, El-Kersh K, Saad M, et al. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Eur Respir Rev, 2016, 25(140): 178-188.
28.	Holter JC, Müller F, Bjørang O, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis, 2015, 15: 64.
29.	Cillóniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax, 2011, 66(4): 340-346.
30.	徐毛治, 刘艳茹, 张青梅. 不同采样技术对社区获得性肺炎病原学的诊断价值. 国际呼吸杂志, 2009, 29(20): 1232-1233.
31.	刘策, 叶芳. 我国社区获得性肺炎病原学分布特点. 中国医药导报, 2016, 13(15): 55-58.

1. 中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南 (2016 年版). 中华结核和呼吸杂志, 2016, 39(4): 253-279.
2. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax, 2009, 64(Suppl 3): iii1-iii55.
3. Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U. S. Adults. N Engl J Med, 2015, 373(5): 415-427.
4. 国家卫生和计划生育委员会统计信息中心. 中国卫生和计划生育统计年鉴. (2014-04-26)［2017-10-20］. http://www.nhfpc.gov. cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.html.
5. Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet, 2015, 386(9998): 1097-1108.
6. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis, 2007, 44(Suppl 2): S27-S72.
7. Boyles TH, Brink A, Calligaro GL, et al. South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis, 2017, 9(6): 1469-1502.
8. Miyashita N, Matsushima T, Oka M. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med, 2006, 45(7): 419-428.
9. Rozenbaum MH, Pechlivanoglou P, van der Werf T, et al. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis, 2013, 32(3): 305-316.
10. Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia - etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest, 2000, 118(5): 1344-1354.
11. Liu Y, Chen M, Zhao T, et al. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population. BMC Infect Dis, 2009, 9: 31.
12. Tao LL, Hu BJ, He LX, et al. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J (Engl), 2012, 125(17): 2967-2972.
13. 李群, 李为民, 高属生, 等. 四川地区社区获得性肺炎的病原学调查. 华西医学, 2008, 23(2): 275-277.
14. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med, 2016, 37(6): 819-828.
15. Marchello C, Dale AP, Thuy NT, et al. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a Meta-analysis. Ann Fam Med, 2016, 14(6): 552-566.
16. 刘又宁, 陈民钧, 赵铁梅, 等. 中国城市成人社区获得性肺炎 665 例病原学多中心调查. 中华结核和呼吸杂志, 2006, 29(1): 3-8.
17. 熊祎虹, 邓锐, 付荣荣, 等. 非典型病原菌致成人社区获得性肺炎患者的临床特点分析. 中华结核和呼吸杂志, 2010, 33(9): 646-650.
18. Rocha NO, Leite RF, Baldi BG. Update on viral community-acquired pneumonia. Rev Assoc Med Bras, 2013, 59(1): 78-84.
19. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax, 2008, 63(1): 42-48.
20. Charles PG, Whitby M, Fuller AJ, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis, 2008, 46(10): 1513-1521.
21. Alimi Y, Lim WS, Lansbury L, et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol, 2017, 95: 26-35.
22. 刘雅芬, 陈美芳, 高燕, 等. 北京地区成人社区获得性肺炎病原学分析. 中华医学杂志, 2013, 93(26): 2043-2047.
23. 邓紫薇, 仇成凤, 李茂作, 等. 成人社区获得性肺炎主要病原体分布的 Meta 分析. 中国抗生素杂志, 2016, 41(12): 950-955.
24. 佘丹阳. 我国成人社区获得性肺炎病原学与欧美国家的差异. 中华结核和呼吸杂志, 2015, 38(1): 13-15.
25. 赵爽, 邓旺, 王导新, 等. 老年性社区获得性肺炎病原菌及药敏结果分析. 中华老年多器官疾病杂志, 2015, 14(3): 215-219.
26. Cillóniz C, Civljak R, Nicolini A, et al. Polymicrobial community-acquired pneumonia: an emerging entity. Respirology, 2016, 21(1): 65-75.
27. Burk M, El-Kersh K, Saad M, et al. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Eur Respir Rev, 2016, 25(140): 178-188.
28. Holter JC, Müller F, Bjørang O, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis, 2015, 15: 64.
29. Cillóniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax, 2011, 66(4): 340-346.
30. 徐毛治, 刘艳茹, 张青梅. 不同采样技术对社区获得性肺炎病原学的诊断价值. 国际呼吸杂志, 2009, 29(20): 1232-1233.
31. 刘策, 叶芳. 我国社区获得性肺炎病原学分布特点. 中国医药导报, 2016, 13(15): 55-58.

Previous Article
Diagnosis and management of pulmonary nodules
Next Article
Current status of diagnosis and treatment of viral pneumonia in adults

West China Medical Journal

Changes of pathogens for community-acquired pneumonia

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content